Home

Press Releases

BIO Praises U.S. Senate for Passing the Pandemic and All-Hazards Preparedness Reauthorization Act
February 28 2013

BIO lauds the Senate for passing H.R. 307, the Pandemic and All-Hazards Preparedness...

BIO Praises The House of Representatives for Approving H.R. 307, the Pandemic and All-Hazards Preparedness Reauthorization Act
January 25 2013

Bill will accelerate R&D to help support nation’s preparedness against chemical,...

PDUFA V Sets New Course for Regulatory Science – Joint BIO/PhRMA Statement
October 1 2012

Pharmaceutical Research and Manufacturers of America PhRMA President and CEO John J....

IFPMA, BIO and WADA Advance Anti-Doping Collaboration with the Launch of 2 Fields 1 Goal Campaign
July 23 2012

Groups issue booklet to help biotechnology and pharmaceutical companies identify pipeline...

Supreme Court Affordable Care Act Ruling Must Now Lead to Implementation That Will Promote Innovation and Expand Access
June 28 2012

Biotechnology Industry Organization (BIO) President and CEO Jim Greenwood issued the...

BIO Commends Senate for Approval of User Fee Package
June 27 2012

Biotechnology Industry Organization (BIO) President and CEO Jim Greenwood released the...

BIO Announces Dr. Michael Rosenblatt, Merck Chief Medical Officer, as Keynote Speaker for the BIO Convention in China
June 13 2012

BIO China event will be held October 24-25 in Shanghai  

BIO Lauds Senate Passage of User Fee Package
May 24 2012

BIO commends the bipartisan Senate approval of FDASIA, which includes a reauthorization of the...

BIO Statement on New Bill to Extend Therapeutic Discovery Project Tax Credit
May 24 2012

BIO applauds Senator Robert Menendez for introducing the “The Extension of the Therapeutic...

Senator Enzi Honored as BIO Legislator of the Year
April 24 2012

The Biotechnology Industry Organization (BIO) announced today its selection of Senator Michael...

Representative Schwartz Honored as BIO Legislator of the Year
April 24 2012

The Biotechnology Industry Organization (BIO) announced today its selection of Representative...

Senator Hagan Honored as BIO Legislator of the Year
April 24 2012

The Biotechnology Industry Organization (BIO) announced today its selection of Senator Kay...

Representative Rogers Honored as BIO Legislator of the Year
April 24 2012

The Biotechnology Industry Organization (BIO) announced today its selection of Representative...

Senator Bob Menendez Honored as BIO Legislator of the Year
April 24 2012

The Biotechnology Industry Organization (BIO) announced today its selection of Senator Robert...

Representative Kingston Honored as BIO Legislator of the Year
April 24 2012

The Biotechnology Industry Organization (BIO) announced today its selection of Representative...

BIO Submits Comments on FDA Draft Guidances on Biosimilars
April 17 2012

The Biotechnology Industry Organization (BIO) submitted comments yesterday to the U.S. Food...

BIO Supports Permanent Reauthorization of Programs to Encourage Development of Lifesaving Medications for Children
March 28 2012

H.R. 4274 will encourage continued investment in pediatric research.

FAST Act Would Provide Patients with Accelerated Access to Innovative Therapies
March 6 2012

The FAST Act will modernize the Accelerated Approval pathway to expedite the...

TREAT Act Offers Renewed Hope for Patients
February 15 2012

The bill will modernize the FDA and accelerate patient access to cures and new treatments.

Administration‘s 2013 Budget Could Discourage Development of Cures and Breakthrough Medicines, Limit Patient Choice And Forestall Job Growth
February 14 2012

“The biotechnology industry has long been an engine for economic development and job...

Release of FDA Guidance for Biosimilars Pathway Marks Important Step Forward, Says BIO
February 9 2012

BIO President and CEO Jim Greenwood issued the following statement regarding the newly...

9th Annual BIO Asia International Conference to Feature New Deal Models and Discuss the Future of Innovation in Asia
January 12 2012

Biotechnology Industry Organization (BIO) announces programming for 2012 event, to be held in...

BIO Strongly Supports Reauthorization of PAHPA and BioShield Special Reserve Fund
November 15 2011

Biotechnology Industry Organization (BIO) President and CEO Jim Greenwood issued the following...

BIO Announces First Chinese American Cabinet Secretary Elaine L. Chao as Keynote Speaker for BIO China International Conference
September 20 2011

Elaine Chao will provide a keynote address at the upcoming inaugural BIO China International...

BIO Supports Timely Reauthorization of PDUFA to Promote the Development of Innovative Therapies and Speed New Medicines to Patients
September 1 2011

Biotechnology Industry Organization (BIO) President and CEO Jim Greenwood released the...

Stem Cell Ruling Will Enable Critical Research to Move Forward Toward Cures and Breakthrough Medicines
July 27 2011

BIO praised today’s ruling by a U.S. District Court dismissing a lawsuit that sought to...

BIO Endorses “Declaration Against Doping in Sport"
June 28 2011

BIO announced its endorsement of the “Joint Declaration on Cooperation in the Fight...

Leaders in Government, Biotechnology and Global Health Examine Innovative Ways to Accelerate Development of New Tools for Global Health
June 15 2011

High-level members of the Obama Administration will gather with leaders from the...

BIO Statement on New Bill to Extend Therapeutic Discovery Project Tax Credit
May 25 2011

BIO commends Reps. Davis (D-Ca) and Schwartz (D-PA) for their continued efforts to extend the...

Representative Upton Honored as BIO Legislator of the Year
May 4 2011

BIO announces selection of Congressman Fred Upton (R-MI) as Legislator of the Year for 2010 -...

Senator Casey Honored as BIO Legislator of the Year
May 4 2011

BIO announced today its selection of Senator Bob Casey (D-PA) as Legislator of the Year for...

Congressman Price Honored as BIO Legislator of the Year
May 4 2011

BIO announces its selection of Representative David E. Price (D-NC) as Legislator of the Year...

Representative Capuano Honored as BIO Legislator of the Year
May 4 2011

BIO announces its selection of Michael Capuano (D-MA) as Legislator of the Year for 2010 -...

Congressman Price Honored as BIO Legislator of the Year
May 4 2011

The Biotechnology Industry Organization (BIO) announced today its selection of Representative...

Representative Capuano Honored as BIO Legislator of the Year
May 4 2011

The Biotechnology Industry Organization (BIO) announced today its selection of Congressman...

2011 BIO International Convention to Host New Forum on Diabetes
May 3 2011

BIO along with the Juvenile Diabetes Research Foundation (JDRF) will feature a two-day...

BIO Announces Dr. Jörg Reinhardt as Keynote Speaker for BIO China International Conference
April 19 2011

BIO announces that Dr. Jörg Reinhardt, CEO of Bayer HealthCare, will provide the keynote...

BIO Announces Policy Panel Keynote Session for 2011 BIO International Convention
April 19 2011

Democratic and Republican party leaders and strategists will share their differing...

NIH Director Dr. Francis Collins to Present Keynote Address at Partnering for Global Health Forum 2011
March 16 2011

NIH Director Francis Collins, MD, PhD will share his insights on how ground-breaking biotech...

BIO Hails U.S. Supreme Court Decision on Vaccine Act
February 22 2011

BIO issues statement commending today’s ruling by the U.S. Supreme Court in ...

New Study Shows the Rate of Drug Approvals Lower than Previously Reported
February 14 2011

Biotechnology Industry Organization (BIO) Industry Analysis and  BioMedTracker (BMT)...

The Future of Healthcare Policy to be Plenary Discussion at 13th Annual BIO CEO & Investor Conference
February 9 2011

BIO announces that former Senator John B. Breaux (D-LA), former Member, Senate Finance...

America’s Biotechnology Sector – Answering President Obama’s Call For Job Growth and Innovation
January 26 2011

BIO's commends President Obama for highlighting the need to increase our nation...

Thirteenth Annual BIO CEO & Investor Conference Therapeutic Sessions to Focus on Oncology, Rheumatoid Arthritis, and Psychiatry
January 12 2011

Experts chosen to speak on these panels represent leading clinical institutions, medical...

Challenges in Reimbursement Hamper Development of Novel Diagnostics
January 6 2011

BIO releases a report by Health Advances on the limitations of the nation’s...

Media Registration for the 2011 BIO International Convention Now Available Online
January 3 2011

The 2011 BIO International Convention will highlight the latest trends and the newest...

BIO Announces Initial Selection of Life Sciences Companies to Present at the 13th Annual BIO CEO & Investor Conference
December 13 2010
Media Registration for 13th Annual BIO CEO & Investor Conference Now Available Online
December 1 2010
BIO to Host Synthetic Biology Workshop at 2010 Pacific Rim Summit on Industrial Biotech and Bioenergy
November 24 2010
Final Biosimilars Pathway Must Make Patient Safety and Incentives For Continued Innovation Top Priorities, Says BIO
November 3 2010
BIO, Other Advanced Biofuels Organizations Ask Administration for Renewed Focus on Next Generation Biofuel Technologies
October 21 2010
BIO Hails Court of Appeals Action to Lift Injunction on Embryonic Stem Cell Research
September 29 2010
BIO Comments on Court Injunction Blocking Federal Funding of Embryonic Stem Cell Research
August 24 2010
BIO Praises Public Health Medical Countermeasures Enterprise Review As Critical First Step in National Preparedness
August 20 2010
BIO Applauds Obama Administration’s Guidance for Therapeutic Discovery Project Program
May 21 2010
BIO Hosts Numerous High-Ranking Public Officials at 2010 BIO International Convention
May 4 2010
New BIO Report Highlights Value of Biotechnology to Individuals and Society
May 4 2010

A new report issued by the Biotechnology Industry Organization underscores how biotechnology...

National Bioscience Report Shows Some Growth Even During Recession
May 3 2010
BIO Announces New Policy on Options for Increasing Access to Medicines in the Developing World
May 3 2010
BIO Statement on Health Care Reform
March 22 2010

Biotechnology Industry Organization (BIO) President and CEO Jim Greenwood released the...

Provisions in the Senate Health Care Bill Help Patients, Promote Innovation, Encourage Job Growth
December 24 2009
Eighth Annual BIO Investor Forum to Address Health Care Reform, Current Issues and Opportunities in the Biotech Industry
October 15 2009

The Biotechnology Industry Organization (BIO) today announced Plenary Session and Business...

BIO/Thomson Reuters Investor Perception Study: Biotechnology Industry is Expected to Rebound
August 12 2009
BIO Applauds President Obama’s Action to Expand Federal Funding of Embryonic Stem Cell Research
March 9 2009
Incentives to Develop Medicines for Neglected Diseases Highlighted at 2008 BIO International Convention
June 18 2008
BIO Celebrates Senate Passage of PDUFA Reauthorization Package
September 21 2007

Biotechnology Industry Organization (BIO) President and CEO Jim Greenwood released the...

BIO Commends House for Approving PDUFA Reauthorization Package
September 19 2007

Biotechnology Industry Organization (BIO) President and CEO Jim Greenwood released the...

BIO Commends Senate for Passage of Stem Cell Research Enhancement Act
April 12 2007
BIO Urges Senate Committee on Finance Not to Limit Patients’ Access to Therapies
April 12 2007

S. 3 Would Weaken Medicare Part D Drug Benefit

New Study Confirms Innovative Therapies Will Have Minimal Impact on Healthcare Costs
April 10 2007

The widening use of new, innovative biopharmaceutical treatments for diseases, such as cancer,...

New Survey Counters Claims Regarding Single Source Therapies in Medicare Part D
February 26 2007

Private Sector Negotiations for Medicare Part D Provide Savings and Access to Innovative...

Recommended Improvements to Prescription Drug User Fee Program Will Improve Drug Safety
January 11 2007

The recommended improvements to the Prescription Drug User Fee Act (PDUFA) announced today by...

Bioscience Industry Fuels Jobs and Growth for States, Industry Study Finds
April 10 2006
Peter Young to Testify on BioShield
April 5 2006
BIO and 21 Patient Groups Issue Letter Supporting FDA’s Critical Path Initiative
January 13 2006
Hawaii Summit to Highlight Marine Biotechnology Discoveries, Benefits
January 6 2006
Greenwood Praises Passage of Pandemic Influenza Plan
December 22 2005
Medicare Drug Coverage Will Expand Access to Biotech Products
November 25 2003

Carl B. Feldbaum, president of the Biotechnology Industry Organization (BIO), today issued the...

BIO STATEMENT ON FDA COMMISSIONER
October 18 2002
House Passes Bioterrorism/PDUFA Legislation in 425-1 Vote
May 22 2002

The House of Representatives today voted 425-1 to approve “The Public Health Security...

Report Details Biotechnology's Contributions On Baby-Boomer Health, Quality of Life
October 5 2000
BIO President Addresses FDA on PDUFA
September 18 2000
AHA AND BIO FORM COALITION
June 30 1999
Clinton Plan Another Step In Debate That's Critically Important To Seniors And Biotech
June 29 1999
President's Medicare Proposal Could Be Key to Both Seniors' and Biotechnology Industry's Health
June 26 1999
BIO to Testify at Senate Finance Committee Hearing on Medicare Modernization
June 22 1999
BIO Adds Medicare Section To Its Web Site
May 11 1999
BIO '99 Attracts Record International Contingent
May 6 1999
BIO Responds To Geron And Roslin Merger
May 4 1999
Compaq's Ben Rosen To Speak At BIO '99
April 29 1999
BIO Strongly Backs U.S. Sen. Bennett's Efforts To Protect Patient Confidentiality
April 27 1999
BIO '99 To Explore Debate Over Financing Drug Benefits For Seniors
April 22 1999
BIO Responds To New Kennedy/Stark Medicare Bill
April 20 1999
BIO '99 To Feature Presentations on Genomics, Molecular Medicine
April 15 1999
BIO '99 To Feature Presentations On Women's Health Issues
April 8 1999
Biotech Industry Adopts Statement Opposing Discriminatory Misuse Of Medical Information
April 8 1999
Kennedy, Johnson Bill Could Cause Medicine Deficit
March 31 1999
BIO Statement on Medicare Reform
March 29 1999
BIO Supports Doubling NIH Budget By 2003
March 16 1999
BIO '99 Expected To Be Record Setting International Showcase
March 8 1999
Price Controls Promise Only To Undermine Biotech Drug Development
February 11 1999
Women's Health Issues Explored At BIO CEO & Investor Conference
February 8 1999
52 Companies To Make Presentations At BIO's Annual CEO & Investor Conference
January 19 1999
BIO Statement on Iceland Genetic Data
January 15 1999
BIO Urges President's Bioethics Advisory Panel To Consider Issues Raised By Stem Cell Research
November 12 1998
BIO CEO & Investor Conference Presentations Target Specific Diseases, Therapies
November 11 1998
BIO Welcomes Verification of Dolly's Cloning, Stands by Ban on Human Cloning
July 22 1998
Biotech Forum To Focus On Cancer Breakthroughs
May 15 1998
Growing Scope, Impact of Biotechnology Showcased at BIO'98
May 15 1998
BIO Supports Doubling NIH Budget over Five Years
March 20 1998
Senate Votes Down Effort to Expedite Ban on Human Cloning
February 11 1998
BIO Responds to Cloning Report
January 7 1998
BIO Looks Forward to Implementation of FDA Reforms
November 21 1997
BIO Calls on President Clinton to Sign FDA Reform Bill Into Law
November 10 1997
BIO lauds House of Representatives for "Moving FDA in New Direction" with passage of H.R. 1411
November 7 1997
BIO Supports Ban on Cloning of Humans, Seeks Medical Research Protection
June 7 1997
International Biotechnology Community Supports Genetic Privacy - BIO Seeks White House Support
June 5 1997
Biotechnology: Old Texas Money Fuels High-Tech "Gushers"
May 13 1997
BIO Reacts to Sheep Cloning Experiment
February 23 1997
BIO Calls for Strong Protections for Genetic Information
February 1 1997

Letters, Testimony & Comments

BIO’s comments on the Centers for Medicare and Medicaid Services’ (CMS) draft 2014 Call Letter
March 1 2013
  BIO’s comments on the Centers for Medicare and Medicaid Services’ (CMS) draft 2014 Call Letter, submitted Friday,...
SMU: BIO Comments on Creating an Alternative Approval Pathway for Certain Drugs to Address Unmet Medical Need
March 1 2013
  The Biotechnology Industry Organization (BIO) thanks the Food and Drug Administration (FDA) for the opportunity to submit...
Cell and Gene Therapy: BIO Comments on Preclinical Assessment of Investigational Cellular and Gene Therapy Products
February 27 2013
    Dear Sir/Madam:    The Biotechnology Industry Organization (BIO) thanks the Food and Drug Administration...
Medicaid, Children’s Health Insurance Programs, and Exchanges
February 21 2013
Ms. Marilyn Tavenner, B.S.N., M.H.A. Acting Administrator Centers for Medicare & Medicaid Services Room 445–G, Hubert H....
Electronic Submissions: BIO Comments on Providing Submissions in Electronic Format
February 19 2013
    The Biotechnology Industry Organization (BIO) thanks the Food and Drug Administration (FDA or Agency) for the...
More Letters, Testimony & Comments →

Press Releases

BIO Praises U.S. Senate for Passing the Pandemic and All-Hazards Preparedness Reauthorization Act
February 28 2013
WASHINGTON, DC – February 28, 2013 –The Biotechnology Industry Organization (BIO) lauds the Senate for...
BIO Praises The House of Representatives for Approving H.R. 307, the Pandemic and All-Hazards Preparedness Reauthorization Act
January 25 2013
The Biotechnology Industry Organization lauds the House of Representatives for passing H.R. 307, the Pandemic and All...
PDUFA V Sets New Course for Regulatory Science – Joint BIO/PhRMA Statement
October 1 2012
Washington, D.C. (October 1, 2012) — Pharmaceutical Research and Manufacturers of America (PhRMA) President and...
IFPMA, BIO and WADA Advance Anti-Doping Collaboration with the Launch of 2 Fields 1 Goal Campaign
July 23 2012
Groups Issue Booklet to Help Biotechnology and Pharmaceutical Companies Identify Pipeline Medicines with Doping...
Supreme Court Affordable Care Act Ruling Must Now Lead to Implementation That Will Promote Innovation and Expand Access
June 28 2012
  Pleased to move forward on biosimilars pathway Washington, D.C. (June 28, 2012) –Biotechnology...
More Press Releases →